Document Detail

Mechanism of disease: Pulmonary hypertension.
MedLine Citation:
PMID:  20704929     Owner:  NLM     Status:  In-Data-Review    
Extract: Pulmonary hypertension (PH) was previously termed primary (idiopathic or of unknown origin, i.e., spontaneous) or secondary (as a result of another disorder) pulmonary hypertension. It is now clear, however, that many of the entities labeled as secondary pulmonary hypertension resemble primary pulmonary hypertension in both their histopathological features and their response to treatment. For this reason, the World Health Organization (WHO) has recently classified PH into five groups on the basis of their proposed underlying mechanism. Group I in this classification, designated pulmonary arterial hypertension, is the focus of this overview. Pulmonary arterial hypertension (PAH) is defined as a sustained elevation of the pulmonary arterial pressure to greater than 25 mmHg at rest or greater than 30 mmHg following exercise, with a mean pulmonary-capillary wedge pressure (an indirect measure of left atrial pressure) of less than 15 mmHg. The entities within the category of PAH include idiopathic pulmonary arterial hypertension (IPAH; formerly, primary pulmonary hypertension), PAH associated with collagen vascular disease (e.g., in limited systemic sclerosis), portal hypertension (high pressure in the vessel that carries blood from the intestines to the liver), congenital left-to-right intra-cardiac shunts, infection with the human immunodeficiency virus (HIV), and persistent pulmonary hypertension of the newborn. The histological appearance of lung vessels in each of these conditions is similar: intimal fibrosis (formation of fibrous material in the inner lining of the blood vessel), increased medial thickness, pulmonary arteriolar occlusion (block of arterioles [the vessels that join the arteries and capillaries] in the lung), and plexiform (web-like) lesions predominate.
Harrison W Farber; Joseph Loscalzo
Related Documents :
4015959 - Invasive pulmonary haemangiomatosis.
21041689 - Proteomic analysis of lung tissues from patients with pulmonary arterial hypertension.
10864099 - Age-related arterial calcification in rats.
2608319 - Acute effect of molsidomine on pulmonary circulation of patients with chronic obstructi...
7661649 - Evaluation of penile arteries in papaverine-induced erection with color doppler ultraso...
17494809 - Pulmonary hypertension due to a retained totally implantable venous access device fragm...
1317709 - Daily variations of the involvement of beta-receptors in the sympathetic nerve action o...
22719159 - Multiple instances of peripheral artery emboli from occult primary small cell lung cancer.
16385279 - Percutaneous endovascular repair of blunt thoracic aortic transection.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Discovery medicine     Volume:  5     ISSN:  1944-7930     ISO Abbreviation:  Discov Med     Publication Date:  2005 Feb 
Date Detail:
Created Date:  2010-08-13     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101250006     Medline TA:  Discov Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  80-7     Citation Subset:  -    
Whitaker Cardiovascular Institute and Evans Department of Medicine, Boston University School of Medicine, Boston, MA 02118, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Pharmacokinetics of drugs administered in nanosuspension.
Next Document:  Global gene expression profiles reveal pathways related to the pathogenesis of chronic obstructive p...